Practical monitoring rhythms matter, with dose-change reviews recommended every 8 to 12 weeks and routine follow-ups every 3 to 6 months once stable
However, the cardiovascular effects, including blood pressure lowering, may provide additional benefit for certain patient groups
Jujic A, Atabaki-Pasdar N, Nilsson PM, Almgren P, Hakaste L, Tuomi T, Berglund LM, Franks PW, Holst JJ, Prasad RB, et al
And its effects ripple through your metabolism for weeks, sometimes months, after your final dose
OZEMPIC also reduced the annual rate of change in eGFR (Figure 9), the incidence of a composite cardiovascular endpoint, consisting of non-fatal myocardial infarction (MI), non-fatal stroke, and cardiovascular death, and the incidence of all-cause death (Table 10 and Figure 8)